• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Warby Parker Announces Fourth Quarter and Full Year 2025 Results

    2/26/26 6:45:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care
    Get the next $WRBY alert in real time by email

    Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the fourth quarter and full year ended December 31, 2025.

    Highlights

    • Delivered revenue growth of 13.0% for full year 2025 and 11.2% for the fourth quarter.
    • Drove Active Customer growth of 7.0%, and Average Revenue per Customer of $324, up 5.7% year over year.
    • Achieved first full year of positive net income of $1.6 million, and expanded Adjusted EBITDA(1) by 30.2% year over year to $95.2 million and Adjusted EBITDA Margin(1) by 140 basis points to 10.9%.
    • Delivered third consecutive year of positive operating cash flow and Free Cash Flow(1) in 2025 of $110.8 million and $43.7 million, respectively.
    • Opened 47 net new stores during the year, ending 2025 with 323 stores.
    • Authorized a $100 million share repurchase program to complement strategic growth investments in the business.

    "In 2025, we delivered double-digit revenue growth each quarter and achieved our first full year of positive net income while expanding Adjusted EBITDA," said Dave Gilboa, Co-Founder and Co-CEO. "In a dynamic environment, we leveraged our unmatched value proposition to capture additional market share while giving customers more convenient options to shop with us than ever before."

    "As we look ahead, we are focused on laying the groundwork for accelerating growth. We are moving decisively into Warby Parker's next act, one defined by groundbreaking innovation and AI that will redefine how our customers experience eyewear and vision care," added Co-Founder and Co-CEO Neil Blumenthal.

    Fourth Quarter 2025 Year-Over-Year Financial Results

    • Net revenue increased $21.3 million, or 11.2%, to $212.0 million.
    • Gross margin was 52.4% compared to 54.1% in the prior year. The decrease in gross margin was primarily driven by tariff costs related to glasses, increased doctor headcount, sales growth of contact lenses, and increased customer shipping costs as a percent of revenue, partially offset by selective price increases in glasses taken in the second quarter and increased penetration of progressives and other lens enhancements.
    • Selling, general and administrative expenses ("SG&A") increased $5.4 million to $117.9 million, or 55.6% of revenue, down 340 basis points from 59.0% in the prior year. As a percentage of revenue, SG&A decreased primarily due to leverage from corporate expenses and efficiencies in our customer experience operations, as well as lower stock-based compensation. Adjusted SG&A(1) was $110.3 million, or 52.0% of revenue, compared to $103.0 million, or 54.0% of revenue, in the prior year.
    • Net loss improved $0.9 million to $6.0 million, primarily as a result of leveraging our expense base on higher revenue.
    • Adjusted EBITDA(1) increased $1.4 million to $15.2 million, and Adjusted EBITDA Margin(1) of 7.2% was roughly flat with the prior year.

    Full Year 2025 Year-Over-Year Financial Results

    • Net revenue increased $100.6 million, or 13.0%, to $871.9 million.
    • Gross margin was 54.0% compared to 55.3% in the prior year. The decrease in gross margin was primarily driven by tariff costs related to glasses, sales growth of contact lenses, increased doctor headcount, and increased customer shipping costs as a percent of revenue, partially offset by selective price increases in glasses taken in the second quarter and increased penetration of progressives and other lens enhancements.
    • SG&A increased $19.0 million to $475.9 million, or 54.6% of revenue, down 460 basis points from 59.2% in the prior year. As a percentage of revenue, SG&A decreased primarily due to leverage from corporate expenses and efficiencies in our customer experience operations, as well as lower stock-based compensation. Adjusted SG&A(1) was $433.3 million, or 49.7% of revenue, compared to $405.2 million, or 52.5% of revenue in the prior year.
    • Net income improved $22.0 million to $1.6 million, primarily as a result of leveraging our expense base on higher revenue.
    • Adjusted EBITDA(1) increased $22.1 million to $95.2 million, and Adjusted EBITDA Margin(1) increased 140 basis points to 10.9%.

    Balance Sheet and Cash Flow Highlights

    • Ended fiscal year 2025 with $286.4 million in cash and cash equivalents.
    • Net cash provided by operating activities of $110.8 million in 2025; $43.7 million of full year Free Cash Flow(1), our third consecutive year of positive operating cash flow and Free Cash Flow(1).

    Share Repurchase Program

    In February 2026, the Company's Board of Directors authorized a share repurchase program to purchase up to $100.0 million of the Company's Class A common stock (the "Share Repurchase Program"). Repurchases under the Share Repurchase Program may be made in the open market, in privately negotiated transactions, or otherwise, with the amount and timing of repurchases to be determined at the Company's discretion, depending on market conditions and corporate needs. Open market repurchases will be structured to occur in accordance with applicable federal securities laws, including within the pricing and volume requirements of Rule 10b-18 under the Securities Exchange Act of 1934, as amended. The Company may also, from time to time, enter into Rule 10b5-1 plans to facilitate repurchases of its shares under this authorization. The Share Repurchase Program does not have a fixed expiration date, does not obligate the Company to acquire any particular amount of Class A common stock, and may be modified, suspended, or terminated at any time at the discretion of the Company's Board of Directors.

    2026 Outlook

    For the full year 2026, Warby Parker is providing the following guidance:

    • Net revenue of $959 to $976 million, representing approximately 10% to 12% growth versus full year 2025.
    • Adjusted EBITDA(1) of $117 to $119 million, which equates to an Adjusted EBITDA Margin(1) of 12.2% across the revenue range, and 130 basis points of year-over-year expansion.
    • 50 new store openings.

    "Our healthy balance sheet and strong cash flows allow us to invest in our strategic growth initiatives as we scale our business over time, while maintaining the flexibility to return capital to shareholders," said Adrian Mitchell, Chief Financial Officer. "I am incredibly energized by Warby Parker's compelling brand promise. By marrying exceptional style with superior quality and outstanding value, we've effectively positioned our business for exciting growth opportunities on the horizon."

    (1) Please see the definitions and reconciliations of non-GAAP financial measures to the most comparable GAAP financial measures in the section titled "Non-GAAP Financial Measures" below.

    Webcast and Conference Call

    A conference call to discuss Warby Parker's fourth quarter and full year 2025 results, as well as first quarter and full year 2026 outlook, is scheduled for 8:00 a.m. ET today. To participate, please dial 833-470-1428 from the U.S. or 646-844-6383 from international locations. The conference passcode is 275034. A live webcast of the conference call will be available on the investors section of the Company's website at investors.warbyparker.com where presentation materials will also be posted prior to the conference call. A replay will be made available online approximately two hours following the live call for a period of 90 days.

    About Warby Parker

    Warby Parker (NYSE:WRBY) was founded in 2010 with a mission to inspire and impact the world with vision, purpose, and style–without charging a premium for it. Headquartered in New York City, the co-founder-led lifestyle brand pioneers ideas, designs products, and develops technologies that help people see, from designer-quality prescription glasses (starting at $95) and contacts, to eye exams and vision tests available online and in its 323 retail stores across the U.S. and Canada.

    Warby Parker aims to demonstrate that businesses can scale, do well, and do good in the world. Ultimately, the brand believes in vision for all, which is why for every pair of glasses or sunglasses sold, they distribute a pair to someone in need through their Buy a Pair, Give a Pair program. To date, Warby Parker has worked alongside its nonprofit partners to distribute more than 20 million glasses to people in need.

    Forward-Looking Statements

    This press release and the related conference call, webcast and presentation contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements may relate to, but are not limited to, expectations of future operating results or financial performance; expectations regarding the growth of our business, delivering stakeholder value and growing market share; expectations regarding the development of new products; expectations regarding our share repurchase program; our guidance for the quarter ending March 31, 2026, and year ending December 31, 2026; expectations regarding the number of new store openings during the year ending December 31, 2026; and management's plans, priorities, initiatives and strategies. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. In some cases, you can identify forward-looking statements because they contain words such as "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "toward," "will," or "would," or the negative of these words or other similar terms or expressions. You should not put undue reliance on any forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved, if at all.

    Forward-looking statements are based on information available at the time those statements are made and are based on current expectations, estimates, forecasts, and projections as well as the beliefs and assumptions of management as of that time with respect to future events. These statements are subject to risks and uncertainties, many of which involve factors or circumstances that are beyond our control, that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. In light of these risks and uncertainties, the forward-looking events and circumstances discussed in this press release may not occur and actual results could differ materially from those anticipated or implied in the forward-looking statements. These risks and uncertainties include our ability to manage our future growth effectively; our expectations regarding cost of goods sold, gross margin, channel mix, customer mix, and selling, general, and administrative expenses; potential disruptions to our supply chain; changes to U.S. or other countries' trade policies and tariff and import/export regulations; our reliance on our information technology systems and enterprise resource planning systems for our business to effectively operate and safeguard confidential information; our ability to invest in and incorporate new technologies into our products and services; risks related to our use of artificial intelligence; our ability to engage our existing customers and obtain new customers; our ability to expand in-network access with insurance providers; planned new retail stores in 2026 and going forward; an overall decline in the health of the economy and other factors impacting consumer spending, such as recessionary conditions, inflation, infectious diseases, government instability, and geopolitical unrest; our ability to compete successfully; our ability to manage our inventory balances and shrinkage; the growth of our brand awareness; our ability to recruit and retain optometrists, opticians, and other vision care professionals; the effects of seasonal trends on our results of operations; our ability to stay in compliance with extensive laws and regulations that apply to our business and operations; our ability to adequately maintain and protect our intellectual property and proprietary rights; our reliance on third parties for our products, operation and infrastructure; our duties related to being a public benefit corporation; the ability of our Co-Founders and Co-CEOs to exercise significant influence over all matters submitted to stockholders for approval; the effect of our multi-class structure on the trading price of our Class A common stock; our ability to collaborate with partners with successful results; our ability to recognize the anticipated benefits from partnerships, including with Google and Samsung; the increased expenses associated with being a public company; and risks related to climate change and severe weather. Additional information regarding these and other risks and uncertainties that could cause actual results to differ materially from the Company's expectations is included in our most recent reports filed with the SEC on Form 10-K and Form 10-Q, which may be obtained by visiting the SEC's website at www.sec.gov. Except as required by law, we do not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise.

    Glossary

    Active Customers is defined as unique customer accounts that have made at least one purchase in the preceding 12-month period.

    Average Revenue per Customer is defined as the sum of the total net revenues in the preceding 12-month period divided by the current period Active Customers.

    Non-GAAP Financial Measures

    We use Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Cost of Goods Sold ("Adjusted COGS"), Adjusted Gross Margin, Adjusted Gross Profit, Adjusted Selling, General, and Administrative Expenses ("Adjusted SG&A"), and Free Cash Flow as important indicators of our operating performance. Collectively, we refer to these non-GAAP financial measures as our "Non-GAAP Measures." The Non-GAAP Measures, when taken collectively with our GAAP results, may be helpful to investors because they provide consistency and comparability with past financial performance and assist in comparisons with other companies, some of which use similar non-GAAP financial information to supplement their GAAP results.

    Adjusted EBITDA is defined as net income before interest and other income, taxes, and depreciation and amortization as further adjusted for asset impairment costs, stock-based compensation expense and related employer payroll taxes, amortization of cloud-based software implementation costs, non-cash charitable donations, charges for certain legal matters outside the ordinary course of business, and non-recurring costs such as restructuring costs and major system implementation costs. Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by net revenue.

    Adjusted COGS is defined as cost of goods sold adjusted for stock-based compensation expense and related employer payroll taxes and non-recurring costs.

    Adjusted Gross Profit is defined as net revenue minus Adjusted COGS. Adjusted Gross Margin is defined as Adjusted Gross Profit divided by net revenue.

    Adjusted SG&A is defined as SG&A adjusted for stock-based compensation expense and related employer payroll taxes, non-cash charitable donations, charges for certain legal matters outside the ordinary course of business, and non-recurring costs such as restructuring costs and major system implementation costs.

    Free Cash Flow is defined as net cash provided by operating activities minus purchases of property and equipment.

    The Non-GAAP Measures are presented for supplemental informational purposes only. A reconciliation of historical GAAP to Non-GAAP financial information is included under "Selected Financial Information" below.

    We have not reconciled our Adjusted EBITDA Margin guidance to GAAP net income (loss) margin, or net margin, or Adjusted EBITDA guidance to GAAP net income (loss) because we do not provide guidance for GAAP net margin or GAAP net income (loss) due to the uncertainty and potential variability of stock-based compensation and taxes, which are reconciling items between GAAP net margin and Adjusted EBITDA Margin and GAAP net income (loss) and Adjusted EBITDA, respectively. Because such items cannot be reasonably provided without unreasonable efforts, we are unable to provide a reconciliation of the Adjusted EBITDA Margin guidance to GAAP net margin and Adjusted EBITDA guidance to GAAP net income (loss). However, such items could have a significant impact on GAAP net margin and GAAP net income (loss).

    Selected Financial Information

    Warby Parker Inc. and Subsidiaries

    Consolidated Balance Sheets (Unaudited)

    (Amounts in thousands, except par value)

     

    December 31,

     

    2025

     

    2024

    Assets

     

     

     

    Current assets:

     

     

     

    Cash and cash equivalents

    $

    286,358

     

     

    $

    254,161

     

    Accounts receivable, net

     

    3,285

     

     

     

    1,948

     

    Inventory

     

    44,512

     

     

     

    52,345

     

    Prepaid expenses and other current assets

     

    18,283

     

     

     

    17,592

     

    Total current assets

     

    352,438

     

     

     

    326,046

     

     

     

     

     

    Property and equipment, net

     

    187,448

     

     

     

    170,464

     

    Right-of-use lease assets

     

    170,805

     

     

     

    171,284

     

    Other assets

     

    10,228

     

     

     

    8,696

     

    Total assets

    $

    720,919

     

     

    $

    676,490

     

     

     

     

     

    Liabilities and Stockholders' Equity

     

     

     

    Current liabilities:

     

     

     

    Accounts payable

    $

    31,979

     

     

    $

    23,519

     

    Accrued expenses

     

    49,225

     

     

     

    51,609

     

    Deferred revenue

     

    33,869

     

     

     

    32,358

     

    Current lease liabilities

     

    31,399

     

     

     

    20,235

     

    Other current liabilities

     

    3,658

     

     

     

    2,633

     

    Total current liabilities

     

    150,130

     

     

     

    130,354

     

     

     

     

     

    Non-current lease liabilities

     

    201,749

     

     

     

    205,120

     

    Other liabilities

     

    1,310

     

     

     

    943

     

    Total liabilities

     

    353,189

     

     

     

    336,417

     

    Commitments and contingencies

     

     

     

    Stockholders' equity:

     

     

     

    Common stock, $0.0001 par value; Class A: 750,000 shares authorized at December 31, 2025 and 2024, 106,318 and 102,889 shares issued and outstanding as of December 31, 2025 and 2024, respectively; Class B: 150,000 shares authorized at December 31, 2025 and 2024, 16,130 and 17,961 shares issued and outstanding as of December 31, 2025 and 2024, respectively, convertible to Class A on a one-to-one basis

     

    12

     

     

     

    12

     

    Additional paid-in capital

     

    1,054,779

     

     

     

    1,029,220

     

    Accumulated deficit

     

    (685,580

    )

     

     

    (687,221

    )

    Accumulated other comprehensive income

     

    (1,481

    )

     

     

    (1,938

    )

    Total stockholders' equity

     

    367,730

     

     

     

    340,073

     

    Total liabilities and stockholders' equity

    $

    720,919

     

     

    $

    676,490

     

    Warby Parker Inc. and Subsidiaries

    Consolidated Statements of Operations (Unaudited)

    (Amounts in thousands, except per share data)

     

    Three Months Ended December 31,

     

    Year Ended December 31,

     

    2025

     

    2024

     

    2023

     

    2025

     

    2024

     

    2023

    Net revenue

    $

    211,968

     

     

    $

    190,643

     

     

    $

    161,855

     

     

    $

    871,905

     

     

    $

    771,315

     

     

    $

    669,765

     

    Cost of goods sold

     

    100,925

     

     

     

    87,517

     

     

     

    74,789

     

     

     

    401,326

     

     

     

    344,481

     

     

     

    304,541

     

    Gross profit

     

    111,043

     

     

     

    103,126

     

     

     

    87,066

     

     

     

    470,579

     

     

     

    426,834

     

     

     

    365,224

     

     

     

     

     

     

     

     

     

     

     

     

     

    Selling, general, and administrative expenses

     

    117,895

     

     

     

    112,542

     

     

     

    108,635

     

     

     

    475,915

     

     

     

    456,946

     

     

     

    437,220

     

    Loss from operations

     

    (6,852

    )

     

     

    (9,416

    )

     

     

    (21,569

    )

     

     

    (5,336

    )

     

     

    (30,112

    )

     

     

    (71,996

    )

     

     

     

     

     

     

     

     

     

     

     

     

    Interest and other income, net

     

    1,761

     

     

     

    2,632

     

     

     

    2,417

     

     

     

    8,379

     

     

     

    10,597

     

     

     

    9,232

     

     

     

     

     

     

     

     

     

     

     

     

     

    (Loss) income before income taxes

     

    (5,091

    )

     

     

    (6,784

    )

     

     

    (19,152

    )

     

     

    3,043

     

     

     

    (19,515

    )

     

     

    (62,764

    )

    Provision for (benefit from) income taxes

     

    862

     

     

     

    93

     

     

     

    (105

    )

     

     

    1,402

     

     

     

    875

     

     

     

    433

     

    Net (loss) income

    $

    (5,953

    )

     

    $

    (6,877

    )

     

    $

    (19,047

    )

     

    $

    1,641

     

     

    $

    (20,390

    )

     

    $

    (63,197

    )

     

     

     

     

     

     

     

     

     

     

     

     

    (Loss) earnings per share:

     

     

     

     

     

     

     

     

     

     

     

    Basic

    $

    (0.05

    )

     

    $

    (0.06

    )

     

    $

    (0.16

    )

     

    $

    0.01

     

     

    $

    (0.17

    )

     

    $

    (0.54

    )

    Diluted

    $

    (0.05

    )

     

    $

    (0.06

    )

     

    $

    (0.16

    )

     

    $

    0.01

     

     

    $

    (0.17

    )

     

    $

    (0.54

    )

     

     

     

     

     

     

     

     

     

     

     

     

    Weighted average shares outstanding:

     

     

     

     

     

     

     

     

     

     

     

    Basic

     

    123,192

     

     

     

    121,409

     

     

     

    118,570

     

     

     

    122,670

     

     

     

    120,385

     

     

     

    117,389

     

    Diluted

     

    123,192

     

     

     

    121,409

     

     

     

    118,570

     

     

     

    125,100

     

     

     

    120,385

     

     

     

    117,389

     

    Warby Parker Inc. and Subsidiaries

    Consolidated Statements of Cash Flows (Unaudited)

    (Amounts in thousands)

     

    Year Ended December 31,

     

    2025

     

    2024

     

    2023

    Cash flows from operating activities

     

     

     

     

     

    Net income (loss)

    $

    1,641

     

     

    $

    (20,390

    )

     

    $

    (63,197

    )

    Adjustments to reconcile net income (loss) to net cash provided by operating activities:

     

     

     

     

     

    Depreciation and amortization

     

    50,280

     

     

     

    45,865

     

     

     

    38,554

     

    Stock-based compensation

     

    34,536

     

     

     

    47,294

     

     

     

    70,509

     

    Non-cash charitable contribution

     

    2,821

     

     

     

    2,196

     

     

     

    3,191

     

    Asset impairment charges

     

    557

     

     

     

    816

     

     

     

    3,230

     

    Amortization of cloud-based software implementation costs

     

    3,405

     

     

     

    3,704

     

     

     

    2,895

     

    Change in operating assets and liabilities:

     

     

     

     

     

    Accounts receivable, net

     

    (1,337

    )

     

     

    (169

    )

     

     

    (345

    )

    Inventory

     

    7,833

     

     

     

    9,889

     

     

     

    6,614

     

    Prepaid expenses and other assets

     

    (5,631

    )

     

     

    (3,233

    )

     

     

    (3,276

    )

    Accounts payable

     

    8,500

     

     

     

    689

     

     

     

    1,633

     

    Accrued expenses

     

    (2,691

    )

     

     

    9,521

     

     

     

    (8,898

    )

    Deferred revenue

     

    1,511

     

     

     

    741

     

     

     

    5,989

     

    Lease assets and liabilities

     

    8,272

     

     

     

    1,920

     

     

     

    4,459

     

    Other liabilities

     

    1,088

     

     

     

    (99

    )

     

     

    (367

    )

    Net cash provided by operating activities

     

    110,785

     

     

     

    98,744

     

     

     

    60,991

     

    Cash flows from investing activities

     

     

     

     

     

    Purchases of property and equipment

     

    (67,048

    )

     

     

    (64,032

    )

     

     

    (53,671

    )

    Investment in optical equipment company

     

    —

     

     

     

    (2,000

    )

     

     

    (1,000

    )

    Net cash used in investing activities

     

    (67,048

    )

     

     

    (66,032

    )

     

     

    (54,671

    )

    Cash flows from financing activities

     

     

     

     

     

    Proceeds from stock option exercises

     

    159

     

     

     

    2,701

     

     

     

    1,036

     

    Shares withheld for taxes on stock-based compensation

     

    (14,390

    )

     

     

    —

     

     

     

    —

     

    Proceeds from shares issued in connection with ESPP

     

    2,204

     

     

     

    1,925

     

     

     

    1,835

     

    Other financing activity

     

    30

     

     

     

    333

     

     

     

    —

     

    Net cash (used in) provided by financing activities

     

    (11,997

    )

     

     

    4,959

     

     

     

    2,871

     

    Effect of exchange rates on cash

     

    457

     

     

     

    (404

    )

     

     

    (882

    )

    Net increase in cash and cash equivalents

     

    32,197

     

     

     

    37,267

     

     

     

    8,309

     

    Cash and cash equivalents

     

     

     

     

     

    Beginning of year

     

    254,161

     

     

     

    216,894

     

     

     

    208,585

     

    End of year

    $

    286,358

     

     

    $

    254,161

     

     

    $

    216,894

     

    Supplemental disclosures

     

     

     

     

     

    Cash paid for income taxes

    $

    776

     

     

    $

    1,035

     

     

    $

    419

     

    Cash paid for interest

     

    325

     

     

     

    246

     

     

     

    227

     

    Non-cash investing and financing activities:

     

     

     

     

     

    Purchases of property and equipment included in accounts payable and accrued expenses

    $

    5,191

     

     

    $

    4,420

     

     

    $

    3,647

     

    Warby Parker Inc. and Subsidiaries

    Reconciliation of GAAP to Non-GAAP Measures (Unaudited)

    The following table reconciles adjusted EBITDA and adjusted EBITDA margin to the most directly comparable GAAP measure, which is net (loss) income:

     

    Three Months Ended

    December 31,

     

    Year Ended

    December 31,

     

    2025

     

    2024

     

    2025

     

    2024

     

     

     

     

     

     

     

     

     

    (unaudited, in thousands)

     

    (unaudited, in thousands)

    Net (loss) income

    $

    (5,953

    )

     

    $

    (6,877

    )

     

    $

    1,641

     

     

    $

    (20,390

    )

    Adjusted to exclude the following:

     

     

     

     

     

     

     

    Interest and other income, net

     

    (1,761

    )

     

     

    (2,631

    )

     

     

    (8,379

    )

     

     

    (10,596

    )

    Provision for income taxes

     

    862

     

     

     

    93

     

     

     

    1,402

     

     

     

    875

     

    Depreciation and amortization expense

     

    13,101

     

     

     

    12,332

     

     

     

    50,280

     

     

     

    45,865

     

    Asset impairment charges

     

    46

     

     

     

    294

     

     

     

    557

     

     

     

    816

     

    Stock-based compensation expense(1)

     

    6,606

     

     

     

    9,036

     

     

     

    36,097

     

     

     

    48,409

     

    Non-cash charitable donations(2)

     

    —

     

     

     

    —

     

     

     

    2,821

     

     

     

    2,196

     

    Amortization of cloud-based software implementation costs

     

    1,013

     

     

     

    842

     

     

     

    3,405

     

     

     

    3,704

     

    System implementation costs(3)

     

    710

     

     

     

    —

     

     

     

    1,883

     

     

     

    —

     

    Inventory write-downs(4)

     

    —

     

     

     

    —

     

     

     

    2,456

     

     

     

    —

     

    Other costs(5)

     

    622

     

     

     

    753

     

     

     

    3,048

     

     

     

    2,232

     

    Adjusted EBITDA

    $

    15,246

     

     

    $

    13,842

     

     

    $

    95,211

     

     

    $

    73,111

     

    Adjusted EBITDA Margin

     

    7.2

    %

     

     

    7.3

    %

     

     

    10.9

    %

     

     

    9.5

    %

    (1) 

    Represents expenses related to the Company's equity-based compensation programs and related employer payroll taxes, which may vary significantly from period to period depending upon various factors including the timing, number, and the valuation of awards granted, and vesting of awards including the satisfaction of performance conditions. For the three and twelve months ended December 31, 2025, the amount includes $0.3 million and $1.6 million of employer payroll costs, respectively, associated with releases of RSUs and option exercises. For the three and twelve months ended December 31, 2024, the amount includes $0.4 million and $1.1 million of employer payroll costs, respectively, associated with releases of RSUs and option exercises.

    (2) 

    Represents charitable expense recorded in connection with the donation of 178,572 shares of Class A common stock in both May 2025 and May 2024 to the Warby Parker Impact Foundation.

    (3) 

    Represents costs related to the implementation of major new enterprise software systems.

    (4) 

    Represents one-time inventory write-downs primarily related to the decision in the second quarter of 2025 to sunset our Home-Try On program at the end of 2025.

    (5) 

    Primarily represents restructuring costs incurred in the second quarter of 2025 and the fourth quarter of 2024 and charges for certain legal matters outside the ordinary course of business.

    Warby Parker Inc. and Subsidiaries

    Reconciliation of GAAP to Non-GAAP Measures (Unaudited)

    The following table presents our non-GAAP, or adjusted, financial measures for the periods presented as a percentage of revenue. Each cost and operating expense is adjusted for stock-based compensation expense and related employer payroll taxes, non-cash charitable donations, charges for certain legal matters outside the ordinary course of business, and non-recurring costs such as restructuring costs and major system implementation costs.

     

    Reported

     

    Adjusted

     

    Reported

     

    Adjusted

     

    Three Months Ended

    December 31,

     

    Three Months Ended

    December 31,

     

    Year Ended

    December 31,

     

    Year Ended

    December 31,

     

    2025

     

    2024

     

    2025

     

    2024

     

    2025

     

    2024

     

    2025

     

    2024

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    (unaudited, in thousands)

     

    (unaudited, in thousands)

     

    (unaudited, in thousands)

     

    (unaudited, in thousands)

    Cost of goods sold

    $

    100,925

     

     

    $

    87,517

     

     

    $

    100,623

     

     

    $

    87,262

     

     

    $

    401,326

     

     

    $

    344,481

     

     

    $

    397,685

     

     

    $

    343,416

     

    % of revenue

     

    47.6

    %

     

     

    45.9

    %

     

     

    47.5

    %

     

     

    45.8

    %

     

     

    46.0

    %

     

     

    44.7

    %

     

     

    45.6

    %

     

     

    44.5

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Gross profit

    $

    111,043

     

     

    $

    103,126

     

     

    $

    111,345

     

     

    $

    103,381

     

     

    $

    470,579

     

     

    $

    426,834

     

     

    $

    474,220

     

     

    $

    427,899

     

    % of revenue

     

    52.4

    %

     

     

    54.1

    %

     

     

    52.5

    %

     

     

    54.2

    %

     

     

    54.0

    %

     

     

    55.3

    %

     

     

    54.4

    %

     

     

    55.5

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Selling, general, and administrative expenses

    $

    117,895

     

     

    $

    112,542

     

     

    $

    110,259

     

     

    $

    103,008

     

     

    $

    475,915

     

     

    $

    456,946

     

     

    $

    433,251

     

     

    $

    405,174

     

    % of revenue

     

    55.6

    %

     

     

    59.0

    %

     

     

    52.0

    %

     

     

    54.0

    %

     

     

    54.6

    %

     

     

    59.2

    %

     

     

    49.7

    %

     

     

    52.5

    %

    Warby Parker Inc. and Subsidiaries

    Reconciliation of GAAP to Non-GAAP Measures (Unaudited)

    The following table reflects a reconciliation of each non-GAAP, or adjusted, financial measure to its most directly comparable financial measure prepared in accordance with GAAP:

     

    Three Months Ended

    December 31,

     

    Year Ended

    December 31,

     

    2025

     

    2024

     

    2025

     

    2024

     

     

     

     

     

     

     

     

     

    (unaudited, in thousands)

     

    (unaudited, in thousands)

    Cost of goods sold

    $

    100,925

     

     

    $

    87,517

     

     

    $

    401,326

     

     

    $

    344,481

     

    Adjusted to exclude the following:

     

     

     

     

     

     

     

    Stock-based compensation expense(1)

     

    302

     

     

     

    255

     

     

     

    1,185

     

     

     

    1,065

     

    Inventory write-downs(2)

     

    —

     

     

     

    —

     

     

     

    2,456

     

     

     

    —

     

    Adjusted Cost of Goods Sold

    $

    100,623

     

     

    $

    87,262

     

     

    $

    397,685

     

     

    $

    343,416

     

     

     

     

     

     

     

     

     

    Gross profit

    $

    111,043

     

     

    $

    103,126

     

     

    $

    470,579

     

     

    $

    426,834

     

    Adjusted to exclude the following:

     

     

     

     

     

     

     

    Stock-based compensation expense(1)

     

    302

     

     

     

    255

     

     

     

    1,185

     

     

     

    1,065

     

    Inventory write-downs(2)

     

    —

     

     

     

    —

     

     

     

    2,456

     

     

     

    —

     

    Adjusted Gross Profit

    $

    111,345

     

     

    $

    103,381

     

     

    $

    474,220

     

     

    $

    427,899

     

     

     

     

     

     

     

     

     

    Selling, general, and administrative expenses

    $

    117,895

     

     

    $

    112,542

     

     

    $

    475,915

     

     

    $

    456,946

     

    Adjusted to exclude the following:

     

     

     

     

     

     

     

    Stock-based compensation expense(1)

     

    6,304

     

     

     

    8,781

     

     

     

    34,912

     

     

     

    47,344

     

    Non-cash charitable donations(3)

     

    —

     

     

     

    —

     

     

     

    2,821

     

     

     

    2,196

     

    System implementation costs(4)

     

    710

     

     

     

    —

     

     

     

    1,883

     

     

     

    —

     

    Other costs(5)

     

    622

     

     

     

    753

     

     

     

    3,048

     

     

     

    2,232

     

    Adjusted Selling, General, and Administrative Expenses

    $

    110,259

     

     

    $

    103,008

     

     

    $

    433,251

     

     

    $

    405,174

     

     

     

     

     

     

     

     

     

    Net cash provided by operating activities

    $

    23,254

     

     

    $

    19,912

     

     

    $

    110,785

     

     

    $

    98,744

     

    Purchases of property and equipment

     

    (15,120

    )

     

     

    (17,721

    )

     

     

    (67,048

    )

     

     

    (64,032

    )

    Free Cash Flow

    $

    8,134

     

     

    $

    2,191

     

     

    $

    43,737

     

     

    $

    34,712

     

    (1) 

    Represents expenses related to the Company's equity-based compensation programs and related employer payroll taxes, which may vary significantly from period to period depending upon various factors including the timing, number, and the valuation of awards granted, and vesting of awards including the satisfaction of performance conditions. For the three and twelve months ended December 31, 2025, the amount includes $0.3 million and $1.6 million of employer payroll costs, respectively, associated with releases of RSUs and option exercises. For the three and twelve months ended December 31, 2024, the amount includes $0.4 million and $1.1 million of employer payroll costs, respectively, associated with releases of RSUs and option exercises.

    (2) 

    Represents charitable expense recorded in connection with the donation of 178,572 shares of Class A common stock in both May 2025 and May 2024 to the Warby Parker Impact Foundation.

    (3) 

    Represents costs related to the implementation of major new enterprise software systems.

    (4) 

    Represents one-time inventory write-downs primarily related to the decision in the second quarter of 2025 to sunset our Home-Try On program at the end of 2025.

    (5) 

    Primarily represents restructuring costs incurred in the second quarter of 2025 and the fourth quarter of 2024 and charges for certain legal matters outside the ordinary course of business.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260226592261/en/

    Investor Relations:

    Jaclyn Berkley, Head of Investor Relations

    Brendon Frey, ICR

    [email protected]



    Media:

    Ali Weltman

    [email protected]

    Get the next $WRBY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $WRBY

    DatePrice TargetRatingAnalyst
    12/10/2025$30.00Mkt Perform → Mkt Outperform
    Citizens JMP
    11/7/2025$28.00 → $24.00Outperform
    Telsey Advisory Group
    8/1/2025$22.00 → $28.00Outperform
    Telsey Advisory Group
    7/10/2025Mkt Outperform → Mkt Perform
    Citizens JMP
    4/30/2025$17.00Sell → Neutral
    Citigroup
    4/17/2025$27.00Hold → Buy
    Loop Capital
    2/28/2025$28.00 → $30.00Outperform
    Telsey Advisory Group
    2/25/2025$26.00Neutral
    ROTH MKM
    More analyst ratings

    $WRBY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Singer Bradley E bought $965,750 worth of shares (75,000 units at $12.88) (SEC Form 4)

    4 - Warby Parker Inc. (0001504776) (Issuer)

    8/14/24 4:52:02 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    $WRBY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Warby Parker upgraded by Citizens JMP with a new price target

    Citizens JMP upgraded Warby Parker from Mkt Perform to Mkt Outperform and set a new price target of $30.00

    12/10/25 9:45:30 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Telsey Advisory Group reiterated coverage on Warby Parker with a new price target

    Telsey Advisory Group reiterated coverage of Warby Parker with a rating of Outperform and set a new price target of $24.00 from $28.00 previously

    11/7/25 7:48:31 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Telsey Advisory Group reiterated coverage on Warby Parker with a new price target

    Telsey Advisory Group reiterated coverage of Warby Parker with a rating of Outperform and set a new price target of $28.00 from $22.00 previously

    8/1/25 8:16:04 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    $WRBY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Financial Officer Mitchell Adrian V

    4 - Warby Parker Inc. (0001504776) (Issuer)

    2/12/26 7:01:12 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    SEC Form 3 filed by new insider Mitchell Adrian V

    3 - Warby Parker Inc. (0001504776) (Issuer)

    2/12/26 6:59:22 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Co-Chief Executive Officer Blumenthal Neil Harris sold $19,793 worth of shares (660 units at $29.99) and converted options into 660 shares (SEC Form 4)

    4 - Warby Parker Inc. (0001504776) (Issuer)

    1/15/26 6:36:33 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    $WRBY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Warby Parker Announces Fourth Quarter and Full Year 2025 Results

    Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the fourth quarter and full year ended December 31, 2025. Highlights Delivered revenue growth of 13.0% for full year 2025 and 11.2% for the fourth quarter. Drove Active Customer growth of 7.0%, and Average Revenue per Customer of $324, up 5.7% year over year. Achieved first full year of positive net income of $1.6 million, and expanded Adjusted EBITDA(1) by 30.2% year over year to $95.2 million and Adjusted EBITDA Margin(1) by 140 basis points to 10.9%. Delivered third consecutive year of positive operating cash

    2/26/26 6:45:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

    Warby Parker Inc. (NYSE:WRBY) (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the fourth quarter and year ended December 31, 2025 will be released before market open on February 26, 2026. In addition, the Company will discuss its results and business outlook during a live conference call and webcast at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing 833-470-1428 from the U.S. or 646-844-6383 from international locations. The conference passcode is 275034. A live webcast of the conference call will be available on the investors section of the Company's website at investors.warbyparker.c

    2/12/26 7:00:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker Appoints Adrian Mitchell as Chief Financial Officer

    Warby Parker Inc. (NYSE:WRBY), a direct-to-consumer lifestyle brand focused on vision for all, today announced the appointment of Adrian Mitchell as Chief Financial Officer, effective February 10, 2026. His appointment strengthens Warby Parker's leadership team as the company continues executing its strategic vision, building on a track record of retail and product innovation while expanding into new categories, including the launch of its first AI glasses. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260209259218/en/Adrian Mitchell, Chief Financial Officer Mitchell has more than 25 years of experience leading some of the worl

    2/9/26 4:10:00 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    $WRBY
    SEC Filings

    View All

    Warby Parker Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    8-K - Warby Parker Inc. (0001504776) (Filer)

    2/26/26 6:46:01 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Warby Parker Inc. (0001504776) (Filer)

    2/9/26 4:19:28 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Warby Parker Inc.

    SCHEDULE 13G/A - Warby Parker Inc. (0001504776) (Subject)

    1/23/26 11:08:18 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    $WRBY
    Leadership Updates

    Live Leadership Updates

    View All

    Warby Parker Appoints Adrian Mitchell as Chief Financial Officer

    Warby Parker Inc. (NYSE:WRBY), a direct-to-consumer lifestyle brand focused on vision for all, today announced the appointment of Adrian Mitchell as Chief Financial Officer, effective February 10, 2026. His appointment strengthens Warby Parker's leadership team as the company continues executing its strategic vision, building on a track record of retail and product innovation while expanding into new categories, including the launch of its first AI glasses. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260209259218/en/Adrian Mitchell, Chief Financial Officer Mitchell has more than 25 years of experience leading some of the worl

    2/9/26 4:10:00 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Monumental Sports & Entertainment Appoints Corporate Finance Executive Steven Miller as Executive Vice President and Chief Financial Officer

    Steven Miller, currently Chief Financial Officer and Treasurer of Warby Parker (NYSE: WRBY), has been appointed Chief Financial Officer of Monumental Sports & Entertainment, effective October 2, 2025, and will join the Senior Executive Leadership TeamAs previously announced, after an extraordinary 25-year career at Monumental Sports & Entertainment, Peter Biché transitioned from Chief Financial Officer to Senior Advisor WASHINGTON, Sept. 9, 2025 /PRNewswire/ -- Monumental Sports & Entertainment (MSE), one of the nation's leading integrated sports, media, and entertainment companies, announced that Steven (Steve) Miller will become its Executive Vice President and Chief Financial Officer (CFO

    9/9/25 6:30:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker appoints Ronald A. Williams as Lead Director and welcomes Bradley E. Singer to Board of Directors

    Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company") announced today the appointment of Ron Williams as Lead Director. "Ron's deep expertise in transformational leadership is helping Warby Parker lead the way in making the optical industry more customer and patient friendly. Our shareholders and our team are lucky to have such an exceptional and experienced leader as our first Lead Director," said Neil Blumenthal, co-Founder and co-CEO. The Company has also appointed a new independent director, Brad Singer, to its board of directors. Mr. Singer's appointment is effective today, August 1, 2024. "Brad brings a wealth of experience as a dynamic operator and investor," said Dav

    8/1/24 4:15:00 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    $WRBY
    Financials

    Live finance-specific insights

    View All

    Warby Parker Announces Fourth Quarter and Full Year 2025 Results

    Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the fourth quarter and full year ended December 31, 2025. Highlights Delivered revenue growth of 13.0% for full year 2025 and 11.2% for the fourth quarter. Drove Active Customer growth of 7.0%, and Average Revenue per Customer of $324, up 5.7% year over year. Achieved first full year of positive net income of $1.6 million, and expanded Adjusted EBITDA(1) by 30.2% year over year to $95.2 million and Adjusted EBITDA Margin(1) by 140 basis points to 10.9%. Delivered third consecutive year of positive operating cash

    2/26/26 6:45:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

    Warby Parker Inc. (NYSE:WRBY) (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the fourth quarter and year ended December 31, 2025 will be released before market open on February 26, 2026. In addition, the Company will discuss its results and business outlook during a live conference call and webcast at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing 833-470-1428 from the U.S. or 646-844-6383 from international locations. The conference passcode is 275034. A live webcast of the conference call will be available on the investors section of the Company's website at investors.warbyparker.c

    2/12/26 7:00:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker Announces Third Quarter 2025 Results

    Net revenue growth accelerated to 15% year over year Active Customers growth accelerated to 9% on a trailing 12-month basis Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the third quarter ended September 30, 2025. "This was a strong quarter for our team as we advanced our strategic priorities and accelerated both topline and customer growth. As we step into Warby Parker's next act, one defined by innovation through AI, we're energized to create new products like AI glasses, enhance the customer experience and drive productivity," shared Co-Founder and Co-CEO Neil Blume

    11/6/25 6:45:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    $WRBY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Warby Parker Inc.

    SC 13G/A - Warby Parker Inc. (0001504776) (Subject)

    11/14/24 5:08:23 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Amendment: SEC Form SC 13G/A filed by Warby Parker Inc.

    SC 13G/A - Warby Parker Inc. (0001504776) (Subject)

    11/14/24 1:30:16 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Amendment: SEC Form SC 13G/A filed by Warby Parker Inc.

    SC 13G/A - Warby Parker Inc. (0001504776) (Subject)

    11/12/24 10:40:28 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care